DRD2 and Huntington disease: The progression of Huntington’s Disease (HD) predominantly impacts spiny projection neurons (SPNs) in the striatum, with Drd2-expressing iSPNs being particularly susceptible compared to Drd1-expressing dSPNs [1, 41].